{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:04:46Z","timestamp":1793293486528,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403020"],"award-info":[{"award-number":["82403020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304025"],"award-info":[{"award-number":["82304025"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303857"],"award-info":[{"award-number":["82303857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: The incidence of thyroid cancer has been increasing in recent years, with papillary thyroid carcinoma (PTC) accounting for the majority of cases. Accumulating studies have demonstrated that S100A10 acts as an oncogene in the progression of various malignancies. However, the function and specific mechanisms of S100A10 in thyroid cancer remain poorly defined. Methods: Single-cell RNA sequencing data of PTC from public databases were analyzed to screen differentially expressed genes (DEGs), among which S100A10 emerged as a potential biomarker associated with PTC metastasis and prognosis. The expression of S100A10 in tissues and cell lines were validated by RT-qPCR and western blot. Protein-protein interactions were confirmed using mass spectrometry analysis and co-immunoprecipitation. The subcellular localization of the protein was determined by immunofluorescence. Stable PTC cell lines overexpressing S100A10 were constructed and followed by transwell assays, wound-healing assays, and western blot for EMT capability detection. Results: S100A10 was found to play essential roles in tumor metastasis and was associated with unfavorable prognosis in patients with PTC. S100A10 was expressed higher in both PTC tissues and cells. Furthermore, both in vitro and in vivo experiments confirmed that S100A10 activates the PI3K\/AKT signaling and promotes EMT in PTC cells, enhancing the invasive capabilities of tumors. S100A10 could interact with both RAN and EGFR intracellularly, forming a RAN-S100A10-EGFR regulatory axis. Finally, several potential drugs targeting S100A10 were identified for further in-depth research. Conclusion: These findings clarify the role of S100A10 and RAN in PTC progression and highlight their potential as therapeutic targets, linking EMT with PI3K\/AKT signaling.<\/jats:p>","DOI":"10.1038\/s41419-026-08649-6","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:07:32Z","timestamp":1776355652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["RAN-S100A10-EGFR axis facilitates papillary thyroid cancer metastasis by PI3K\/AKT signaling"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5578-8117","authenticated-orcid":false,"given":"Wenbin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2908-2507","authenticated-orcid":false,"given":"Zhaoyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cangchang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2879-4282","authenticated-orcid":false,"given":"Guixin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-0737","authenticated-orcid":false,"given":"Zhaohui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3848-1992","authenticated-orcid":false,"given":"Yingxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2053-9866","authenticated-orcid":false,"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4680-6889","authenticated-orcid":false,"given":"Yao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-0985","authenticated-orcid":false,"given":"Feng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3367-9174","authenticated-orcid":false,"given":"Yizeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9977-162X","authenticated-orcid":false,"given":"Xianghui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"8649_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531\u201344.","journal-title":"Lancet"},{"key":"8649_CR2","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"L Davies","year":"2006","unstructured":"Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama. 2006;295:2164\u20137.","journal-title":"Jama"},{"key":"8649_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S1470-2045(07)70034-7","volume":"8","author":"E Baudin","year":"2007","unstructured":"Baudin E, Schlumberger M. New therapeutic approaches for metastatic thyroid carcinoma. Lancet Oncol. 2007;8:148\u201356.","journal-title":"Lancet Oncol"},{"key":"8649_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97:418\u201328.","journal-title":"Am J Med"},{"key":"8649_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00005537-200002010-00001","volume":"110","author":"AR Shaha","year":"2000","unstructured":"Shaha AR. Controversies in the management of thyroid nodule. Laryngoscope. 2000;110:183\u201393.","journal-title":"Laryngoscope"},{"key":"8649_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/BF00353765","volume":"18","author":"GF Scheumann","year":"1994","unstructured":"Scheumann GF, Gimm O, Wegener G, Hundeshagen H, Dralle H. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg. 1994;18:559\u201367. discussion 567-558.","journal-title":"World J Surg"},{"key":"8649_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0071-8","volume":"50","author":"B Hwang","year":"2018","unstructured":"Hwang B, Lee JH, Bang D. Single-cell RNA sequencing technologies and bioinformatics pipelines. Exp Mol Med. 2018;50:1\u201314.","journal-title":"Exp Mol Med"},{"key":"8649_CR8","doi-asserted-by":"crossref","unstructured":"Cheng C, Chen W, Jin H, Chen X. A review of single-cell RNA-Seq annotation, integration, and cell-cell communication. Cells. 2023;12:1970.","DOI":"10.3390\/cells12151970"},{"key":"8649_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03505-z","volume":"24","author":"G Wang","year":"2024","unstructured":"Wang G, Shi C, He L, Li Y, Song W, Chen Z, et al. Identification of the tumor metastasis-related tumor subgroups overexpressed NENF in triple-negative breast cancer by single-cell transcriptomics. Cancer Cell Int. 2024;24:319.","journal-title":"Cancer Cell Int"},{"key":"8649_CR10","doi-asserted-by":"publisher","first-page":"e32976","DOI":"10.1097\/MD.0000000000032976","volume":"102","author":"Y Ren","year":"2023","unstructured":"Ren Y, Chen B, Zhang M, Xu F. Comprehensive analysis of the prognosis of S100 family members and their relationship with tumor-infiltrating immune cells in human pancreatic adenocarcinoma. Medicine. 2023;102:e32976.","journal-title":"Medicine"},{"key":"8649_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB. S100 proteins in cancer. Nat Rev Cancer. 2015;15:96\u2013109.","journal-title":"Nat Rev Cancer"},{"key":"8649_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cca.2021.05.028","volume":"520","author":"T Wang","year":"2021","unstructured":"Wang T, Du G, Wang D. The S100 protein family in lung cancer. Clin Chim Acta. 2021;520:67\u201370.","journal-title":"Clin Chim Acta"},{"key":"8649_CR13","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1016\/j.jid.2022.01.013","volume":"142","author":"Y Li","year":"2022","unstructured":"Li Y, Wu J, Tian Y, Zhu Q, Ge Y, Yu H, et al. MED1 downregulation contributes to TGF\u03b2-induced metastasis by inhibiting SMAD2 ubiquitination degradation in cutaneous melanoma. J Invest Dermatol. 2022;142:2228\u20132237.e2224.","journal-title":"J Invest Dermatol"},{"key":"8649_CR14","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1172\/JCI138577","volume":"130","author":"H Lu","year":"2020","unstructured":"Lu H, Xie Y, Tran L, Lan J, Yang Y, Murugan NL, et al. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. J Clin Invest. 2020;130:4607\u201323.","journal-title":"J Clin Invest"},{"key":"8649_CR15","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1136\/gutjnl-2022-327998","volume":"72","author":"X Wang","year":"2023","unstructured":"Wang X, Huang H, Sze KM, Wang J, Tian L, Lu J, et al. S100A10 promotes HCC development and progression via transfer in extracellular vesicles and regulating their protein cargos. Gut. 2023;72:1370\u201384.","journal-title":"Gut"},{"key":"8649_CR16","doi-asserted-by":"crossref","unstructured":"Lin H, Yang P, Li B, Chang Y, Chen Y, Li Y, et al. S100A10 promotes pancreatic ductal adenocarcinoma cells proliferation, migration and adhesion through JNK\/LAMB3-LAMC2 axis. Cancers. 2022;15:202.","DOI":"10.3390\/cancers15010202"},{"key":"8649_CR17","doi-asserted-by":"publisher","first-page":"16837","DOI":"10.1007\/s00432-023-05420-8","volume":"149","author":"Y Wang","year":"2023","unstructured":"Wang Y, Song W, Li Y, Liu Z, Zhao K, Jia L, et al. Integrated analysis of tumor microenvironment features to establish a diagnostic model for papillary thyroid cancer using bulk and single-cell RNA sequencing technology. J Cancer Res Clin Oncol. 2023;149:16837\u201350.","journal-title":"J Cancer Res Clin Oncol"},{"key":"8649_CR18","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1080\/15384101.2018.1511510","volume":"17","author":"S Li","year":"2018","unstructured":"Li S, Zhou J, Wu H, Lu Q, Tai Y, Liu Q, et al. Oncogenic transformation of normal breast epithelial cells co-cultured with cancer cells. Cell Cycle. 2018;17:2027\u201340.","journal-title":"Cell Cycle"},{"key":"8649_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6:17\u201332.","journal-title":"Cancer Cell"},{"key":"8649_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204819","volume":"10","author":"Y Tian","year":"2023","unstructured":"Tian Y, Chen ZH, Wu P, Zhang D, Ma Y, Liu XF, et al. MIR497HG-derived miR-195 and miR-497 mediate tamoxifen resistance via PI3K\/AKT signaling in breast cancer. Adv Sci. 2023;10:e2204819.","journal-title":"Adv Sci"},{"key":"8649_CR21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ccell.2018.07.009","volume":"34","author":"O Meurette","year":"2018","unstructured":"Meurette O, Mehlen P. Notch signaling in the tumor microenvironment. Cancer Cell. 2018;34:536\u201348.","journal-title":"Cancer Cell"},{"key":"8649_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00109-011-0815-6","volume":"90","author":"M Nipp","year":"2012","unstructured":"Nipp M, Elsner M, Balluff B, Meding S, Sarioglu H, Ueffing M, et al. S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging. J Mol Med. 2012;90:163\u201374.","journal-title":"J Mol Med"},{"key":"8649_CR23","first-page":"2679","volume":"27","author":"Y Ito","year":"2007","unstructured":"Ito Y, Arai K, Nozawa R, Yoshida H, Higashiyama T, Takamura Y, et al. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer Res. 2007;27:2679\u201383.","journal-title":"Anticancer Res"},{"key":"8649_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01616-7","volume":"21","author":"H Zhao","year":"2022","unstructured":"Zhao H, Ming T, Tang S, Ren S, Yang H, Liu M, et al. Wnt signaling in colorectal cancer: pathogenic role and therapeutic target. Mol Cancer. 2022;21:144.","journal-title":"Mol Cancer"},{"key":"8649_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2058-1","volume":"17","author":"S Xu","year":"2019","unstructured":"Xu S, Xu H, Wang W, Li S, Li H, Li T, et al. The role of collagen in cancer: from bench to bedside. J Transl Med. 2019;17:309.","journal-title":"J Transl Med"},{"key":"8649_CR26","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37:4343\u201357.","journal-title":"Oncogene"},{"key":"8649_CR27","first-page":"853","volume":"26","author":"Y Tan","year":"2011","unstructured":"Tan Y, Ma SY, Wang FQ, Meng HP, Mei C, Liu A, et al. Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer. Oncol Rep. 2011;26:853\u20139.","journal-title":"Oncol Rep"},{"key":"8649_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-019-0592-3","volume":"12","author":"L Wang","year":"2019","unstructured":"Wang L, Yan W, Li X, Liu Z, Tian T, Chen T, et al. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin. J Ovarian Res. 2019;12:113.","journal-title":"J Ovarian Res"},{"key":"8649_CR29","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1002\/1878-0261.12356","volume":"12","author":"M Bydoun","year":"2018","unstructured":"Bydoun M, Sterea A, Liptay H, Uzans A, Huang WY, Rodrigues GJ, et al. S100A10, a novel biomarker in pancreatic ductal adenocarcinoma. Mol Oncol. 2018;12:1895\u2013916.","journal-title":"Mol Oncol"},{"key":"8649_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bbrc.2018.09.118","volume":"505","author":"K Sato","year":"2018","unstructured":"Sato K, Saiki Y, Arai K, Ishizawa K, Fukushige S, Aoki K, et al. S100A10 upregulation associates with poor prognosis in lung squamous cell carcinoma. Biochem Biophys Res Commun. 2018;505:466\u201370.","journal-title":"Biochem Biophys Res Commun"},{"key":"8649_CR31","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s13277-013-0962-1","volume":"34","author":"J Shang","year":"2013","unstructured":"Shang J, Zhang Z, Song W, Zhou B, Zhang Y, Li G, et al. S100A10 as a novel biomarker in colorectal cancer. Tumour Biol. 2013;34:3785\u201390.","journal-title":"Tumour Biol"},{"key":"8649_CR32","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1074\/jbc.M310357200","volume":"279","author":"L Zhang","year":"2004","unstructured":"Zhang L, Fogg DK, Waisman DM. RNA interference-mediated silencing of the S100A10 gene attenuates plasmin generation and invasiveness of Colo 222 colorectal cancer cells. J Biol Chem. 2004;279:2053\u201362.","journal-title":"J Biol Chem"},{"key":"8649_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.559486","volume":"8","author":"Y Li","year":"2020","unstructured":"Li Y, Li XY, Li LX, Zhou RC, Sikong Y, Gu X, et al. S100A10 accelerates aerobic glycolysis and malignant growth by activating mTOR-signaling pathway in gastric cancer. Front Cell Dev Biol. 2020;8:559486.","journal-title":"Front Cell Dev Biol"},{"key":"8649_CR34","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fcell.2020.00345","volume":"8","author":"Z Boudhraa","year":"2020","unstructured":"Boudhraa Z, Carmona E, Provencher D, Mes-Masson AM. Ran GTPase: a key player in tumor progression and metastasis. Front Cell Dev Biol. 2020;8:345.","journal-title":"Front Cell Dev Biol"},{"key":"8649_CR35","doi-asserted-by":"publisher","first-page":"7139","DOI":"10.1038\/onc.2008.325","volume":"27","author":"VV Kurisetty","year":"2008","unstructured":"Kurisetty VV, Johnston PG, Johnston N, Erwin P, Crowe P, Fernig DG, et al. RAN GTPase is an effector of the invasive\/metastatic phenotype induced by osteopontin. Oncogene. 2008;27:7139\u201349.","journal-title":"Oncogene"},{"key":"8649_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3727\/096504013X13747716581417","volume":"21","author":"J Ning","year":"2013","unstructured":"Ning J, Liu W, Zhang J, Lang Y, Xu S. Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway. Oncol Res. 2013;21:67\u201372.","journal-title":"Oncol Res"},{"key":"8649_CR37","doi-asserted-by":"publisher","first-page":"44613","DOI":"10.1074\/jbc.M104993200","volume":"276","author":"R Pawliczak","year":"2001","unstructured":"Pawliczak R, Cowan MJ, Huang X, Nanavaty UB, Alsaaty S, Logun C, et al. p11 expression in human bronchial epithelial cells is increased by nitric oxide in a cGMP-dependent pathway involving protein kinase G activation. J Biol Chem. 2001;276:44613\u201321.","journal-title":"J Biol Chem"},{"key":"8649_CR38","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1016\/j.febslet.2010.10.030","volume":"584","author":"DN Pham","year":"2010","unstructured":"Pham DN, Luo H, Wu J. Reduced Ran expression in Ran(+\/-) fibroblasts increases cytokine-stimulated nuclear abundance of the AP-1 subunits c-Fos and c-Jun. FEBS Lett. 2010;584:4623\u20136.","journal-title":"FEBS Lett"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08649-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:47:17Z","timestamp":1779763637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8649"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08649-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The design of this study was approved by Ethical Committee of Tianjin Medical University General Hospital (IRB2023-DWFL-164; IRB2023-KY-123) and was consistent with the ethical guidelines of the Helsinki Declaration. Informed and written consent was acquired from all involved patients. All co-authors have consented the version of manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"510"}}